- Epstein - Barr virus - associated lymphoid proliferations, a 2018 update
Sherif A. Rezk et al, 2018, Human Pathology CrossRef - Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
Rou-Jun Peng et al, 2018, Leukemia CrossRef - New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015–December 2015
J. Han van Krieken, 2016, J Hematopathol CrossRef - Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma
Qingqing Cai et al, 2019, Front. Oncol. CrossRef - Non-coding RNAs in Natural Killer/T-Cell Lymphoma
Mei Mei et al, 2019, Front. Oncol. CrossRef - EBV–Associated Lymphoproliferative Disorders
Sherif A. Rezk et al, 2019, Surgical Pathology Clinics CrossRef - A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway
Yuan Mao et al, 2017, Oncotarget CrossRef - The landscape of new drugs in extranodal NK/T-cell lymphoma
Liang Wang et al, 2020, Cancer Treatment Reviews CrossRef - Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs
Kotaro Miyao et al, 2018, Cancer Immunol Res CrossRef - Eukaryotic initiating factor eIF4E is targeted by EBV-encoded miR-BART11-3p and regulates cell cycle and apoptosis in EBV-associated gastric carcinoma
Hanqing Wang et al, 2021, Virus Genes CrossRef - The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins.
Yang Wang et al, 2021, BMC Cancer CrossRef - Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma
Ajay Major et al, 2023, Cancers CrossRef - EBV and Lymphomagenesis
Daniel G. Sausen et al, 2023, Cancers CrossRef - Novel target and treatment agents for natural killer/T-cell lymphoma
Xiao-Peng Tian et al, 2023, J Hematol Oncol CrossRef - Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma
Linyan Xu et al, 2023, J Pharmacol Exp Ther CrossRef - Treatment of Epstein-Barr Virus infection in immunocompromised patients
Martyna Pociupany et al, 2024, Biochemical Pharmacology CrossRef - null
Yuan Tan et al, 2024 CrossRef